Home » Regeneron Scales Up Manufacturing of COVID-19 Antibody Cocktail
Regeneron Scales Up Manufacturing of COVID-19 Antibody Cocktail
Regeneron said it will produce hundreds of thousands of doses of its potential COVID-19 antibody treatment REGN-COV2 by the end of August.
The company expects to begin clinical studies of the antibody “cocktail” therapy next month.
Regeneron is also conducting a phase 2/3 trial with Sanofi to evaluate its rheumatoid arthritis treatment Kevzara (sarilumab) for treating severe COVID-19 infections.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May